CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma
Radiology · 01.04.2023 · 307 (1)
DOI: 10.1148/radiol.221291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiology, erschienen am 01.04.2023. Verfasst von Zhichao Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Radiology (Z.F., H.L., J.D., W.W., P.R.), Pathology (Q.C.), and Infectious Disease (Z.L.), The Third Xiangya Hospital of Cent…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 177-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From the Departments of Radiology (Z.F., H.L., J.D., W.W., P.R.), Pathology (Q.C.), and Infectious Disease (Z.L.), The Third Xiangya Hospital of Central South University, No. 138 Tongzipo Rd, Changsha 410013, China; Dep…
ORCID-Profile: Zhichao Feng, Xiaoping Yu, Zhenguo Liu, Pengfei Rong
Zitieren
APA
Feng, Z., Li, H., Liu, Q., Duan, J., Zhou, W., Yu, X., Chen, Q., Liu, Z., Wang, W., & Rong, P. (2023). CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma. Radiology, 307(1). https://doi.org/10.1148/radiol.221291
Vancouver
Feng Z, Li H, Liu Q, Duan J, Zhou W, Yu X, et al. CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma. Radiology. 2023;307(1). doi:10.1148/radiol.221291
BibTeX
@article{Feng2023,
author = {Feng, Zhichao and Li, Huiling and Liu, Qianyun and Duan, Junhong and Zhou, Wenming and Yu, Xiaoping and Chen, Qian and Liu, Zhenguo and Wang, Wei and Rong, Pengfei},
title = {CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma},
journal = {Radiology},
year = {2023},
volume = {307},
number = {1},
doi = {10.1148/radiol.221291}
}
EUVIMED